Loading

VRTX — VERTEX PHARMACEUTICALS INC / MA · PureTicker

Dashboard Screener Smart Money Ask

More▾

Chart read News S&P 500 Pricing Methodology

☰✕

Dashboard Screener Smart Money Ask

Chart read News S&P 500 Pricing Methodology

VRTX

VERTEX PHARMACEUTICALS INC / MAA8715-min delayed · EOD close

——as of —

Pharmaceutical Preparations · SIC 2834 · CIK 0000875320

Key Stats Financials Fair Value Quality Technicals Peers Smart Money Ratings News

No price history seeded for this security.

Market cap

—

P/E

—

Net margin

35.0%

ROE

21.8%

Revenue

$12.6B

latest annual

Net income

$4.4B

latest annual

Shares out

253M

Free cash flow

$3.8B

52-week range

Not enough price history.

Quality score

87/100

A

Growth74

Business quality87

Chart read News S&P 500 Pricing Methodology Terms Privacy

Research and education only. Not investment advice, not a broker or registered adviser, and no trade execution. Data from SEC EDGAR and Yahoo Finance.

missing: grossMargin

Financial health98

Valuationno data

missing: peRatio, psRatio, pbRatio

Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.